Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients
Overall survival- log rank test was used; fifteen of the 19 GH-high patients died, the median OS was 9.26 months ...
Read moreTag: atezolizumab
Neoadjuvant cisplatin, pemetrexed plus atezolizumab followed by surgical resection, maintenance atezolizumab is safe
Neoadjuvant cisplatin and pemetrexed plus atezolizumab followed by surgical resection and maintenance atezolizumab met safety criteria, according to research presented ...
Read more
